Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID‑19 pneumonia and moderate hyperinflammation. A retrospective cohort study: reply
Ismael Francisco Aomar Millán, Juan Salvatierra, José Hernández‐Quero
Topics & Concepts
MedicineAnakinraTocilizumabMethylprednisolonePneumoniaInternal medicineRetrospective cohort studyGastroenterologyRheumatoid arthritisDiseaseCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19Sepsis Diagnosis and Treatment